We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Group enriched (cervical cancer, head and neck cancer, lung cancer, melanoma, urothelial cancer)
HPA (cell line):
Group enriched (A-431, hTCEpi, RPMI-8226)
HPA (normal tissue):
Tissue enhanced (esophagus, skin)
Protein evidence
Evidence at protein level
Protein expression normal tissue
Ubiquitous cytoplasmic expression, most abundant in squamous epithelia.
ANTIBODY IHC RELIABILITY
Data reliability description
Antibody staining mainly consistent with RNA expression data. Caution, targets protein from more than one gene. Presumed off target binding observed and disregarded.
Most cancer tissues showed weak to moderate cytoplasmic and membranous immunoreactivity. Lymphomas and renal cancers along with several gliomas, ovarian, lung and liver cancers were negative.